SEC Form 4 · accession 0001209191-17-035436
INTEGRA LIFESCIENCES HOLDINGS CORP · IART
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
James M Sullivan
Director
Period of report
May 23, 2017
Accepted (ET)
May 25, 2017 · 4:40 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000917520
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | May 23, 2017 | A | 3,544 | $0.00 | A | 58,040 | D | |
| Common Stock | May 23, 2017 | A | 1,564 | $0.00 | A | 59,604 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1On December 21, 2016, the common stock of Integra LifeSciences Holdings Corporation split two-for-one, resulting in the reporting person's ownership of one additional share of common stock for each share of common stock owned as of that date, as reflected in the totals on the Forms 4 filed subsequent to that date.